Anzeige
Mehr »
Login
Mittwoch, 22.03.2023 Börsentäglich über 12.000 News von 687 internationalen Medien
Starke Signale! 11 Mal “STRONG BUY” + außergewöhnliche News!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NBNG ISIN: US0231112063 Ticker-Symbol: EH3A 
Tradegate
21.03.23
14:39 Uhr
1,545 Euro
+0,075
+5,10 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AMARIN CORPORATION PLC ADR Chart 1 Jahr
5-Tage-Chart
AMARIN CORPORATION PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,54021.03.
1,4751,51021.03.

Aktuelle News zur AMARIN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAmarin Corporation plc: Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl)853New Amarin Board Believes the Company Will Thrive with Proper Stewardship New Amarin Directors are Working with Urgency to Address Issues at Amarin DUBLIN, Ireland and BRIDGEWATER, N.J., March...
► Artikel lesen
07.03.Sarissa's overhaul of Amarin's board is complete with resignation of 7 holdover members15
07.03.Alex Denner's firm takes over Amarin, ousts non-Sarissa board members15
06.03.AMARIN CORP PLC - 8-K, Current Report2
06.03.Amarin says all seven independent non-Sarissa members resigned11
06.03.Amarin Corporation plc: Amarin Announces Board Departures316DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) ("Amarin" or the "Company") today announced that, in the interest of the Company to avoid...
► Artikel lesen
06.03.Amarin touts in vitro data on omega-3 fatty acid EPA in reducing cardiovascular events9
AMARIN Aktie jetzt für 0€ handeln
06.03.Amarin Corporation plc: Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC509--In Vitro Data Presentations Support Antithrombotic and Antioxidant Effects of EPA Compared with DHA, No Impact of Mineral Oil on Rates of LDL Oxidation -- DUBLIN, Ireland and BRIDGEWATER...
► Artikel lesen
06.03.Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome11
05.03.Amarin Corporation plc: Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event494--Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS Without Increased Bleeding-- --Analysis Builds on...
► Artikel lesen
02.03.Amarin's (AMRN) Q4 Earnings and Revenues Beat Estimates11
01.03.Alkermes gains amid speculation Sarissa could wage proxy battle after Amarin win14
01.03.Alex Denner secures victory in Amarin vote, ousting chair and adding supporters to board8
01.03.AMARIN CORP PLC - 10-K, Annual Report2
01.03.Amarin Corporation plc: Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update359-- Company Delivers Positive Free Cash Flow in Fourth Quarter 2022 Following U.S. Revenue Stabilization -- -- Previously Announced Cost Savings Program On-Track to Exceed $100 Million Target -- --...
► Artikel lesen
01.03.AMARIN CORP PLC - 8-K, Current Report3
28.02.Hot Stocks: GOGO, PGNY surge on earnings news; AHCO drops; AMRN proxy fight14
28.02.Amarin Q4 2022 Earnings Preview13
28.02.Amarin 8% higher after Sarissa wins proxy battle with management17
28.02.Amarin Corporation plc: Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders12
Seite:  Weiter >>
119 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2